Research

As a practice we support research studies.

During 2022/2023 Heswall & Pensby Group Practice recruited 1089 participants to 5 NHS research studies.

Clinicalresearchcertificate

Victorion

The Victorion research study aims to find out if the study treatment, called Inclisiran, can help prevent cardiovascular events (such as heart attacks, strokes, procedures to improve blood flow, and death) in adults who are at high cardiovascular risk but have not had a major cardiovascular event, and who also have high cholesterol.

Click on the links below for further information

Prevail Generic Study Information Overview Sheet V2 07NOV2022 Clean

VICTORION-1 PREVENT_Patient information brochure_V1_23Feb23_English (UK)

Discover Me

Discover Me Video

E.mbrace

The E.mbrace Study will assess the effectiveness and safety of an investigational vaccine in the prevention of blood infections in adults aged 60 or over. These blood infections can lead to serious complications such as dangerously low blood pressure or shock.

Click for further info – https://en-gb.embracevaccinestudy.com/#home

The FLASH Study

Although there are several treatment options already available for asthma, some individuals may still have difficulty controlling their symptoms.
Heswall and Pensby Surgery is taking part in the FLASH study which is investigating whether a medication called Atuliflapon can improve symptoms for patients
living with moderate to severe uncontrolled Asthma.
This study is recruiting male and female participants between the age of 18-55 years of age with a confirmed asthma diagnosis.
Heswall and Pensby Surgery is working with our research technology partner uMed to invite patients to this study. If you meet the study criteria, you may receive a text
message, email or letter asking whether you would like to take part. Participation is entirely voluntary and you can opt out at any time.
If you have any questions about this study please contact the uMed nurse support team at patientsupport@umed.io.